XGenomes

XGenomes is building the sequencing technology of the future.

Cambridge, United States · Founded 2017 · $3.0M raised

Employees
1–10
Founded
2017
Total Funding
$3.0M
Last Round
$3.0M SeedAug 2019
Rounds
1

About

At XGenomes, we are building a technology comprising novel biochemistry, hardware and algorithms for sequencing DNA. Our product will be streamlined: there is zero library preparation; we sequence directly on unadulterated single molecules of DNA; DNA extraction will be integrated with sequencing; there is no bioinformatics bottleneck. The sequence we produce will be of unprecedented accuracy due to several layers of in-built redundancy including the sequencing both strands of the double-helix concurrently. The sequence we produce will be complete, encompassing: structural as well as single nucleotide variants; long-range haplotype phase; the repetitive "dark matter" of the genome. The cost of goods (consumables) of sequencing will be <$10, which will allow us to price our product at a level that will help grow the market while still achieving >90% margin. We will start by offering access as a service to high value customers, which be followed by a razor and blade model of selling instruments and consumables.

Summary

XGenomes is a Genomics company based in Cambridge, United States, founded in 2017. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Aug 2019. Investors include Y Combinator Continuity Fund, Amino Capital and Cantos.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedAug 2019
$3.0M

Investors

Similar Companies